Connect your AI

Charles River Laboratories CRL Changes in unrecognized tax benefits

Changes in unrecognized tax benefits at other companies

Thermo Fisher ScientificTMO

——

Other financials

Income statement

Revenue$995.8M+1.2%

Gross profit$349.0M-3.5%

Operating income$119.9M+60.6%

Net income-$14.8M-158%

EPS (diluted)-$0.30-160%

Balance sheet

Cash & equivalents$198.2M-14.5%

Total debt$3.1B+1.9%

Total equity$2.9B-7.9%

Total assets$7.7B+2.0%

Cash flow

Operating cash flow$41.1M-76.1%

CapEx$55.9M-5.8%

Free cash flow-$14.8M-113%

Valuation

Market cap$8.91B+10.3%

Enterprise value$11.79B+8.5%

P/S2.2×+0.2×

Profitability

Gross margin84.7%—

Operating margin13%-2.4pp

Net margin-4.6%—

FCF margin9.7%-4.3pp

Returns & leverage

Return on equity-6%—

Debt / equity1×+0.1×

Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies.

The official record: Charles River Laboratories’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's changes in unrecognized tax benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Charles River Laboratories's changes in unrecognized tax benefits?: Charles River Laboratories (CRL) reported changes in unrecognized tax benefits of 2.7% in Q4 2025.
What does changes in unrecognized tax benefits mean?: The effect of changes in tax reserves on the overall effective tax rate.
How do you interpret changes in unrecognized tax benefits?: A significant positive impact indicates a tax benefit from resolving contingencies, while a negative impact indicates an increase in tax reserves.
How does changes in unrecognized tax benefits compare across companies?: Standard component of the effective tax rate reconciliation table in the income tax footnote.